Search for Clinical Trial Results

Anal Cancer - 81 Studies Found

Status Study
Completed Study Name: Pembrolizumab in Refractory Metastatic Anal Cancer
Condition: Anal Cancer
Date: 2016-09-02
Interventions: Drug: Pembrolizumab Pembrolizumab 200 mg will be administered as a 30 minute IV infusion every 3 weeks.
Completed Study Name: Shared Decision Making With Anal Cancer Patients on Radiation Dose
Condition: Anal Cancer
Date: 2016-05-09
Interventions:
  • Radiation: 2.15 gray and 1.8 gray. Max. 6 weeks.
Completed Study Name: Anal Cancer Screening Study
Condition: Anal Cancer
Date: 2009-06-04
Completed Study Name: Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer
Condition: Anal Cancer
Date: 2009-08-07
Interventions:
  • Biological: cetuximab
  • Drug: cisplatin
Terminated Study Name: Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
Condition: Anal Cancer
Date: 2003-09-10
Interventions:
  • Drug: cisplatin
  • Drug: fluorouracil
Completed Study Name: Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men
Condition: Anal Cancer
Date: 2007-07-12
Recruiting Study Name: Anal Cancer Radiotherapy Study
Condition: Anal Cancer
Date: 2013-08-28
Completed Study Name: Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
Condition: Anal Cancer
Date: 2001-10-11
Interventions:
  • Drug: cisplatin
  • Drug: fluorouracil
Completed Study Name: Individual Following in Anal Cancer With PET/CT
Condition: Anal Cancer
Date: 2016-02-22
Interventions: Other: anal cancer Anal cancer patients with TEP TDM
Active, not recruiting Study Name: A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
Condition: Anal Cancer
Date: 2012-08-07
Interventions:
  • Biological: Treatment ADXS11-0
Next >>>